HAEMONETICS CORPORATION (HAE) FY2027 Q1 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-27

Swipe to see the full flow
HAEMONETICS CORPORATION (HAE) FY2027 Q1 Balance SheetBalance sheet as of 2026-06-27. The chart shows assets, liabilities and equity at that date.Current liabilities$263.24 MCurrent assets$810.83 MLiabilities(calculated)$1.53 BAssets$2.37 BNon-current liabilities$1.27 BNon-current assets$1.55 BEquity$837.10 MGross equity(calculated)$878.73 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInventories, netCash and cash equivalentsAccounts receivable, less allowance for credit losses of $3,618 as of June 27, 2026 and $3,693 as of March 28, 2026Prepaid expenses and other current assetsGoodwillIntangible assets, less accumulated amortization of $374,828 as of June 27, 2026 and $363,763 as of March 28, 2026Property, plant and equipment, netOther long-term assetsDeferred tax assetOther current liabilitiesAccounts payableAccrued payroll and related costsNotes payable and current maturities of long-term debtLong-term debtOther long-term liabilitiesDeferred tax liabilityAdditional paid-in capitalRetained earningsCommon stock, $0.01 par value; Authorized — 150,000,000 shares; Issued and outstanding — 45,471,313 shares as of June 27, 2026 and 45,252,667 shares as of March 28, 2026Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilities (calculated)EquityGross equity (calculated)Accumulated other comprehensive lossOther current liabilitiesOther current liabilities$163.80 MCurrent liabilitiesCurrent liabilities$263.24 MAccounts payableAccounts payable$56.34 MCurrent assetsCurrent assets$810.83 MLiabilities (calculated)Liabilities(calculated)$1.53 BInventories, netInventories, net$306.74 MAccrued payroll and related costsAccrued payroll and related costs$38.15 MAssetsAssets$2.37 BCash and cash equivalentsCash and cash equivalents$223.38 MNotes payable and current maturities of long-term debtNotes payable and current maturities of long-term debt$4.96 MAccounts receivable, less allowance for credit losses of $3,618 as of June 27, 2026 and $3,693 as of March 28, 2026Accounts receivable, net$216.07 MNon-current liabilitiesNon-current liabilities$1.27 BPrepaid expenses and other current assetsPrepaid expenses and other current assets$64.64 MLong-term debtLong-term debt$1.17 BNon-current assetsNon-current assets$1.55 BGoodwillGoodwill$656.88 MEquityEquity$837.10 MOther long-term liabilitiesOther long-term liabilities$57.17 MIntangible assets, less accumulated amortization of $374,828 as of June 27, 2026 and $363,763 as of March 28, 2026Intangible assets, net$434.51 MDeferred tax liabilityDeferred tax liability$38.69 MGross equity (calculated)Gross equity(calculated)$878.73 MProperty, plant and equipment, netProperty, plant and equipment, net$303.78 MAdditional paid-in capitalAdditional paid-in capital$566.76 MOther long-term assetsOther long-term assets$149.96 MDeferred tax assetDeferred tax asset$9.43 MRetained earningsRetained earnings$311.52 MCommon stock, $0.01 par value; Authorized — 150,000,000 shares; Issued and outstanding — 45,471,313 shares as of June 27, 2026 and 45,252,667 shares as of March 28, 2026Common stock$455.00 KAccumulated other comprehensive lossAccumulated other comprehensive loss−$41.63 M
Chart details

HAEMONETICS CORPORATION (HAE) FY2027 Q1 Balance Sheet

Balance sheet as of 2026-06-27. The chart shows assets, liabilities and equity at that date.

Assets
2,365,400,000 US dollars
Current assets
810,832,000 US dollars
Non-current assets
1,554,568,000 US dollars
Liabilities (calculated)
1,528,299,000 US dollars
Current liabilities
263,235,000 US dollars
Non-current liabilities
1,265,064,000 US dollars
Equity
837,101,000 US dollars
Inventories, net
306,739,000 US dollars
Cash and cash equivalents
223,384,000 US dollars
Accounts receivable, less allowance for credit losses of $3,618 as of June 27, 2026 and $3,693 as of March 28, 2026
216,071,000 US dollars
Prepaid expenses and other current assets
64,638,000 US dollars
Goodwill
656,884,000 US dollars
Intangible assets, less accumulated amortization of $374,828 as of June 27, 2026 and $363,763 as of March 28, 2026
434,512,000 US dollars
Property, plant and equipment, net
303,778,000 US dollars
Other long-term assets
149,960,000 US dollars
Deferred tax asset
9,434,000 US dollars
Other current liabilities
163,796,000 US dollars
Accounts payable
56,338,000 US dollars
Accrued payroll and related costs
38,145,000 US dollars
Notes payable and current maturities of long-term debt
4,956,000 US dollars
Long-term debt
1,169,202,000 US dollars
Other long-term liabilities
57,171,000 US dollars
Deferred tax liability
38,691,000 US dollars
Additional paid-in capital
566,759,000 US dollars
Retained earnings
311,516,000 US dollars
Common stock, $0.01 par value; Authorized — 150,000,000 shares; Issued and outstanding — 45,471,313 shares as of June 27, 2026 and 45,252,667 shares as of March 28, 2026
455,000 US dollars
Accumulated other comprehensive loss
negative 41,629,000 US dollars
Gross equity (calculated)
878,730,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
HAEMONETICS CORPORATION (HAE) FY2027 Q1 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!